GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avid Bioservices Inc (STU:TEHN) » Definitions » Cyclically Adjusted Revenue per Share

Avid Bioservices (STU:TEHN) Cyclically Adjusted Revenue per Share : €1.60 (As of Jan. 2024)


View and export this data going back to . Start your Free Trial

What is Avid Bioservices Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Avid Bioservices's adjusted revenue per share for the three months ended in Jan. 2024 was €0.490. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €1.60 for the trailing ten years ended in Jan. 2024.

During the past 12 months, Avid Bioservices's average Cyclically Adjusted Revenue Growth Rate was 8.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 6.50% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -3.40% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was -1.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Avid Bioservices was 22.00% per year. The lowest was -21.20% per year. And the median was 1.00% per year.

As of today (2024-05-30), Avid Bioservices's current stock price is €7.35. Avid Bioservices's Cyclically Adjusted Revenue per Share for the quarter that ended in Jan. 2024 was €1.60. Avid Bioservices's Cyclically Adjusted PS Ratio of today is 4.59.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Avid Bioservices was 24.59. The lowest was 1.11. And the median was 5.10.


Avid Bioservices Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Avid Bioservices's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avid Bioservices Cyclically Adjusted Revenue per Share Chart

Avid Bioservices Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.50 1.26 1.14 1.47 1.40

Avid Bioservices Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.44 1.40 1.56 1.53 1.60

Competitive Comparison of Avid Bioservices's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, Avid Bioservices's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avid Bioservices's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avid Bioservices's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Avid Bioservices's Cyclically Adjusted PS Ratio falls into.



Avid Bioservices Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Avid Bioservices's adjusted Revenue per Share data for the three months ended in Jan. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jan. 2024 (Change)*Current CPI (Jan. 2024)
=0.49/130.1244*130.1244
=0.490

Current CPI (Jan. 2024) = 130.1244.

Avid Bioservices Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201404 0.186 100.023 0.242
201407 0.159 100.520 0.206
201410 0.193 100.176 0.251
201501 0.187 98.604 0.247
201504 0.319 99.824 0.416
201507 0.312 100.691 0.403
201510 0.291 100.346 0.377
201601 0.190 99.957 0.247
201604 0.481 100.947 0.620
201607 0.148 101.524 0.190
201610 0.607 101.988 0.774
201701 0.271 102.456 0.344
201704 0.380 103.167 0.479
201707 0.523 103.278 0.659
201710 0.241 104.070 0.301
201801 0.124 104.578 0.154
201804 0.106 105.708 0.130
201807 0.193 106.324 0.236
201810 0.158 106.695 0.193
201901 0.215 106.200 0.263
201904 0.271 107.818 0.327
201907 0.242 108.250 0.291
201910 0.294 108.577 0.352
202001 0.217 108.841 0.259
202004 0.204 108.173 0.245
202007 0.388 109.318 0.462
202010 0.313 109.861 0.371
202101 0.298 110.364 0.351
202104 0.363 112.673 0.419
202107 0.409 115.183 0.462
202110 0.354 116.696 0.395
202201 0.436 118.619 0.478
202204 0.319 121.978 0.340
202207 0.569 125.002 0.592
202210 0.567 125.734 0.587
202301 0.510 126.223 0.526
202304 0.565 127.992 0.574
202307 0.543 128.974 0.548
202310 0.381 129.810 0.382
202401 0.490 130.124 0.490

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Avid Bioservices  (STU:TEHN) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Avid Bioservices's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=7.35/1.6
=4.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Avid Bioservices was 24.59. The lowest was 1.11. And the median was 5.10.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Avid Bioservices Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Avid Bioservices's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Avid Bioservices (STU:TEHN) Business Description

Industry
Traded in Other Exchanges
Address
14191 Myford Road, Tustin, CA, USA, 92780
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.

Avid Bioservices (STU:TEHN) Headlines

No Headlines